Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 43
Filter
1.
Br J Anaesth ; 123(1): e29-e37, 2019 Jul.
Article in English | MEDLINE | ID: mdl-31029409

ABSTRACT

BACKGROUND: Grading schemes for severity of suspected allergic reactions have been applied to the perioperative setting, but there is no scoring system that estimates the likelihood that the reaction is an immediate hypersensitivity reaction. Such a score would be useful in evaluating current and proposed tests for the diagnosis of suspected perioperative immediate hypersensitivity reactions and culprit agents. METHODS: We conducted a Delphi consensus process involving a panel of 25 international multidisciplinary experts in suspected perioperative allergy. Items were ranked according to appropriateness (on a scale of 1-9) and consensus, which informed development of a clinical scoring system. The scoring system was assessed by comparing scores generated for a series of clinical scenarios against ratings of panel members. Supplementary scores for mast cell tryptase were generated. RESULTS: Two rounds of the Delphi process achieved stopping criteria for all statements. From an initial 60 statements, 43 were rated appropriate (median score 7 or more) and met agreement criteria (disagreement index <0.5); these were used in the clinical scoring system. The rating of clinical scenarios supported the validity of the scoring system. Although there was variability in the interpretation of changes in mast cell tryptase by the panel, we were able to include supplementary scores for mast cell tryptase. CONCLUSION: We used a robust consensus development process to devise a clinical scoring system for suspected perioperative immediate hypersensitivity reactions. This will enable objectivity and uniformity in the assessment of the sensitivity of diagnostic tests.


Subject(s)
Hypersensitivity, Immediate/diagnosis , Intraoperative Complications/diagnosis , Postoperative Complications/diagnosis , Consensus , Humans
2.
Br J Anaesth ; 123(1): e82-e94, 2019 Jul.
Article in English | MEDLINE | ID: mdl-30916014

ABSTRACT

Unsubstantiated penicillin-allergy labels are common in surgical patients, and can lead to significant harm through avoidance of best first-line prophylaxis of surgical site infections and increased infection with resistant bacterial strains. Up to 98% of penicillin-allergy labels are incorrect when tested. Because of the scarcity of trained allergists in all healthcare systems, only a minority of surgical patients have the opportunity to undergo testing and de-labelling before surgery. Testing pathways can be modified and shortened in selected patients. A variety of healthcare professionals can, with appropriate training and in collaboration with allergists, provide testing for selected patients. We review how patients might be assessed, the appropriate testing strategies that can be used, and the minimum standards of safe testing.


Subject(s)
Anesthesia/methods , Anti-Bacterial Agents/adverse effects , Drug Hypersensitivity/diagnosis , Penicillins/adverse effects , Humans
3.
BJA Educ ; 19(10): 313-320, 2019 Oct.
Article in English | MEDLINE | ID: mdl-33456852
7.
Ann Fr Anesth Reanim ; 32(2): 112-4, 2013 Feb.
Article in French | MEDLINE | ID: mdl-23375495

ABSTRACT

Adverse systemic reactions such as cardiovascular effects may occur following topical ocular application of phenylephrine. We report the case of a 49-year-old woman who, following topical application of phenylephrine eyedrops, experienced hypertension with electrocardiographic modifications and a rise in cardiac troponin Ic.


Subject(s)
Hypertension/chemically induced , Mydriatics/adverse effects , Ophthalmic Solutions/adverse effects , Ophthalmologic Surgical Procedures/adverse effects , Ophthalmologic Surgical Procedures/methods , Phenylephrine/adverse effects , Anesthesia, General , Electrocardiography , Female , Humans , Hypertension/blood , Middle Aged , Mydriatics/therapeutic use , Ophthalmic Solutions/therapeutic use , Phenylephrine/therapeutic use , Troponin C/blood
10.
Am J Transplant ; 11(7): 1531-4, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21668638

ABSTRACT

We report a case of transient symptomatic transferred IgE-mediated peanut allergy after elective blood-group compatible liver transplantation. We show that the allergy was transient and therefore passive, authorizing further uneventful peanut consumption. Skin tests with commercial peanut extract and native peanut were performed in the recipient. Circulating specific IgE against peanut and recombinant peanut allergens (rArah1, rArah2, rArah3) was measured in stored serum samples collected from the recipient between 6 months before and 8 months after liver transplantation. Specific IgE levels in the donor were measured at the time of multiorgan donation. In the recipient, diagnosis of IgE-mediated peanut anaphylaxis was based on the clinical history and detection of specific IgE against peanut and recombinant major peanut allergens (rArah1, rArah2 and rArah3). Skin tests were negative and specific IgE undetectable 6 months after the clinical reaction. Oral peanut challenge was negative excluding persistent peanut allergy. This case confirms that IgE-mediated peanut allergy can be transferred by liver transplantation and shows that it may be transient and therefore passively acquired.


Subject(s)
Immunoglobulin E/immunology , Liver Transplantation/immunology , Peanut Hypersensitivity/etiology , Adult , Arachis/immunology , Female , Humans , Male , Middle Aged , Peanut Hypersensitivity/immunology , Skin Tests
11.
Br J Anaesth ; 106(5): 687-9, 2011 May.
Article in English | MEDLINE | ID: mdl-21310720

ABSTRACT

Methylene blue-treated fresh-frozen plasma (MB-FFP) is mainly used in Europe. The advantage of the methylene blue system is that units can be treated individually. The combined action of methylene blue and illumination is a photodynamic process preventing viral RNA and DNA replication. We report the first immediate allergic hypersensitivity reaction to methylene blue-treated plasma transfusion. The clinical course and subsequent assessment of the allergic reaction, including skin tests and basophil activation test, confirmed methylene blue-induced IgE-mediated anaphylaxis. All immediate reactions after MB-FFP transfusion should be investigated to document the underlying mechanism.


Subject(s)
Anaphylaxis/chemically induced , Methylene Blue/adverse effects , Plasma , Anaphylaxis/diagnosis , Basophil Degranulation Test/methods , Humans , Male , Skin Tests/methods , Virus Inactivation , Young Adult
13.
Ann Fr Anesth Reanim ; 29(3): 215-26, 2010 Mar.
Article in French | MEDLINE | ID: mdl-20153947

ABSTRACT

OBJECTIVES: To propose the different modalities of management of the allergic risk occurring during paediatric anaesthesia. STUDY DESIGN: Literature analysis. METHODS: Literature research using the Medline((R)) database and MeSH format according to keywords, including publications in French and English since 1982. RESULTS: The overall incidence for anaphylactic reactions was estimated at one in 7741 anaesthetic procedures during paediatric anaesthesia. Latex anaphylaxis was mostly involved with an incidence at one in 10,159 anesthetic procedures. The risk factors of latex sensitization are known. Primary latex prophylaxis is efficient in patients at risk of latex sensitization. In contrast to adults, neuromuscular blocking agents (NMBAs) are rarely involved in children, with an incidence at 1 in 81,275 anaesthetic procedures. The Ring and Messmer clinical scale allows quantifying the severity and helps managing the care of immediate hypersensitivity reactions. Clinical symptoms associate cardiovascular, respiratory and cutaneous-mucous signs according to different severity grades. Epinephrine associated to fluid loading, remains the first-line agent in case of severe reactions. The allergological assessment is key to the management of these reactions and is required in order to identify the mechanism of the reaction and the culprit drug or substance involved. CONCLUSIONS: Allergic reactions to NMBAs occurring during paediatric anaesthesia are rare whereas those with latex are more frequent. Therefore, the reduction of the allergic risk during paediatric anaesthesia essentially requires a latex-free environment.


Subject(s)
Anesthesia/adverse effects , Hypersensitivity/epidemiology , Intraoperative Complications/epidemiology , Adolescent , Age Factors , Allergens/chemistry , Allergens/immunology , Anaphylaxis/diagnosis , Anaphylaxis/epidemiology , Anaphylaxis/therapy , Bronchial Spasm/drug therapy , Bronchial Spasm/etiology , Bronchodilator Agents/therapeutic use , Child , Child, Preschool , Databases, Factual , Epinephrine/therapeutic use , Female , France/epidemiology , Humans , Hypersensitivity/diagnosis , Hypersensitivity/therapy , Hypersensitivity, Immediate/epidemiology , Infant , Intraoperative Complications/diagnosis , Intraoperative Complications/therapy , Latex Hypersensitivity/epidemiology , Male , Neuromuscular Blocking Agents/adverse effects , Risk Factors , Young Adult
15.
Acta Anaesthesiol Scand ; 53(8): 1092-3, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19496758

ABSTRACT

Immediate allergic hypersensitivity reactions with fentanyl are rarely reported. We diagnosed a presumably IgE-mediated allergic hypersensitivity reaction comprising generalized erythema and bronchospasm 4 h after the first-time application of transdermal fentanyl. Prick test remained negative with fentanyl whereas an intradermal test (IDT) with fentanyl was positive (dilution 10(-2)). Cross-reactivity was found with sufentanil but not with remifentanil. The diagnosis was supported by the clinical history and a positive IDT with fentanyl. This case report confirms the need for a systematic allergological investigation in case of immediate hypersensitivity reactions for all drugs and all modes of administration.


Subject(s)
Analgesics, Opioid/adverse effects , Anaphylaxis/etiology , Fentanyl/adverse effects , Administration, Cutaneous , Albuterol/therapeutic use , Anaphylaxis/drug therapy , Bariatric Surgery , Bronchial Spasm/drug therapy , Bronchial Spasm/etiology , Bronchodilator Agents/therapeutic use , Cross Reactions , Drug Hypersensitivity/drug therapy , Erythema/drug therapy , Erythema/etiology , Female , Humans , Immunoglobulin E/immunology , Middle Aged , Skin Tests
16.
Rev Med Interne ; 30(10): 872-81, 2009 Oct.
Article in French | MEDLINE | ID: mdl-19375199

ABSTRACT

The incidence and morbimortality of immediate hypersensitivity reactions following iodinated contrast media (ICM) injection remain unknown. The diagnosis of an immediate hypersensitivity reaction relies on a triad associating the precise description of the initial clinical manifestations and their delay of onset, the results of the biological assessment performed after the reaction including histamine and tryptase serum level measurements, and the results of skin testing with the culprit agent. Analysis of these data allows identification of the pathophysiologic mechanism of the reaction and the allergen involved in case of allergic hypersensitivity. Skin tests should be performed according to strict criteria. Cross-reactivity with ICM has to be investigated in order to propose a nonreactive ICM for future procedures. Allergic hypersensitivity to a given ICM imposes its definitive avoidance but not the avoidance of all iodinated drugs. The allergenic sequence has not yet been identified but is not the iodine atom itself. Asthma and treatment with beta-blockers are not risk factors of immediate allergic reactions to ICM per se, but may increase their severity. The various published protocols of premedication do not prevent the occurrence of an allergic/anaphylactic reaction to an ICM. The avoidance of the culprit ICM is the only way to prevent further reactions.


Subject(s)
Contrast Media/adverse effects , Hypersensitivity, Immediate/etiology , Humans , Hypersensitivity, Immediate/classification , Hypersensitivity, Immediate/diagnosis , Hypersensitivity, Immediate/therapy , Premedication , Risk Factors
18.
Ann Fr Anesth Reanim ; 28(1): 61-73, 2009 Jan.
Article in French | MEDLINE | ID: mdl-19097849

ABSTRACT

Mastocytosis are characterized by an accumulation of abnormal mast cells in various tissues. Their incidence is estimated at 1/150,000 patients. Pure cutaneous mastocytosis which are mainly observed during childhood may resolve spontaneously during adolescence, whereas systemic mastocytosis involving one or more organs or tissues are more observed in adults. The initial event leading to mastocytosis is believed to be related to activating mutations in c-kit receptor, thus resulting in increased proliferation of mast cells precursors, migration in various tissues and degranulation leading to clinical signs. This nosologic entity does not belong to allergic diseases. Their perioperative management involves a multidisciplinary approach. The degranulation of mast cells with subsequent clinical symptoms can be triggered by psychological, chemical, traumatic, physical (rubbing, extreme temperatures...) agents. Avoiding these triggers should be realized whenever possible according to each patient. The premedication has not proven its efficiency. Tryptase measurement is part of the preoperative biological assessment. The clinical signs severity is related to the cardiovascular homeostasis disturbances (arterial hypotension, cardiovascular collapse, cardiac arrest). The cardiovascular symptoms do not correlate to the cutaneous versus systemic description of the disease. The drug of choice for the treatment of the severe cardiovascular signs is epinephrine associated to vascular loading. The aim of this literature review is to suggest the different modalities of perioperative care of patients with mastocytosis.


Subject(s)
Anesthesia , Mastocytosis, Cutaneous/complications , Mastocytosis, Systemic/complications , Perioperative Care , Adolescent , Adult , Age Factors , Biomarkers , Cell Degranulation , Child , Humans , Mast Cells/physiology , Mastocytosis, Cutaneous/epidemiology , Mastocytosis, Systemic/epidemiology , Preanesthetic Medication , Risk Factors , Tryptases/blood
19.
J Radiol ; 90(10): 1183, 2009 Oct.
Article in French | MEDLINE | ID: mdl-24927676
SELECTION OF CITATIONS
SEARCH DETAIL
...